Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIVANTAMAB vs AMIVANTAMAB-VMJW: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIVANTAMAB vs AMIVANTAMAB-VMJW: Safety Overview

Metric AMIVANTAMAB AMIVANTAMAB-VMJW
Total FAERS Reports 748 2,005
Deaths Reported 116 159
Death Rate 15.5% 7.9%
Hospitalizations 445 362
Average Patient Age 63.5 yrs 66.0 yrs
% Female Patients 65.3% 64.4%
Manufacturer Janssen Biotech, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status N/A Prescription